In-vitro activity of lansoprazole against Helicobacter pylori

The Journal of Antimicrobial Chemotherapy
Natale FiguraM Dattilo

Abstract

Lansoprazole is a gastric parietal cell proton pump inhibitor that is also active against Helicobacter pylori in vitro. We aimed to investigate further the mechanism of its antimicrobial effect. The antimicrobial activity of lansoprazole and of its sulfenamide, a rearrangement product occurring spontaneously in acid environments, was studied by determining the MICs and MBCs for 11 cytotoxic and eight non-cytotoxic H. pylori strains and by measuring the rapidity of bacterial killing. The MIC90 and MBC90 were 2.5 mg/L and 10 mg/L, respectively, both for lansoprazole and for its sulfenamide. Cytotoxic strains were as susceptible as non-cytotoxic strains. The sulfenamide exhibited faster bactericidal activity. Lansoprazole did not inhibit the toxin-induced vacuolization of HeLa cells by a cytotoxic strain, hence its anti-H. pylori activity does not depend on inhibition of a v-ATPase-mediated, toxin-induced activity. Sulfenamide formation is likely to occur in vivo in the gastric environment, thus enhancing the bactericidal activity of the drug. Lansoprazole is likely to be useful, in association with antibiotics, in the treatment of H. pylori infection regardless of the cytotoxicity of the infecting strain.

Citations

Aug 29, 2009·Nature Reviews. Gastroenterology & Hepatology·Kenneth R DeVault, Nicholas J Talley
Jun 26, 1999·Helicobacter·M TrautmannB Glasbrenner
Jan 1, 1999·Journal of Clinical Gastroenterology·M Dattilo, N Figura
Feb 16, 2005·Expert Opinion on Pharmacotherapy·Hidekazu Suzuki, Toshifumi Hibi
Aug 2, 2006·Gastroenterology Clinics of North America·Ratha-Korn VilaichoneDavid Y Graham
Aug 9, 2015·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Rocco Maurizio ZagariMichele Caselli
Nov 24, 2005·Alimentary Pharmacology & Therapeutics·R H Hunt
Jul 17, 2010·Helicobacter·Chao-Hung KuoDeng-Chyang Wu
Jun 23, 1999·The Yale Journal of Biology and Medicine·J A Louw, I N Marks
Sep 1, 1999·The Journal of Pharmacy and Pharmacology·M SasakiiM Itoh
Nov 9, 2016·BMC Complementary and Alternative Medicine·Griselda García-AlonsoMaría Luisa Villarreal
Apr 10, 2015·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Muhammad Miftahussurur, Yoshio Yamaoka
Aug 26, 1998·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·T AlarcónM López-Brea
Apr 19, 2018·Arquivos De Gastroenterologia·Luiz Gonzaga Vaz CoelhoJoaquim Prado de Moraes-Filho
Sep 29, 2019·World Journal of Gastroenterology : WJG·Enzo IerardiAlfredo Di Leo
Dec 5, 2014·World Journal of Gastroenterology : WJG·Chao-Hung KuoFu-Chen Kuo
Jul 26, 2018·Arquivos De Gastroenterologia·Luiz Gonzaga Vaz CoelhoJosé Vitor Zir
Jul 2, 2011·European Journal of Medicinal Chemistry·Rodrigo AboniaJusto Cobo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Scandinavian Journal of Gastroenterology. Supplement
F Burcharth, A Kruse
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
K KubonovaM Kettner
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
H RautelinT U Kosunen
© 2021 Meta ULC. All rights reserved